Back
Ventyx Biosciences Vs. Regulus Therapeutics Industry Stock Comparison
Sell
40
VTYX
Ventyx Biosciences
Last Price:
2.61
Seasonality Move:
49.04%
Sell
50
RGLS
Regulus Therapeutics
Last Price:
1.62
Seasonality Move:
4.04%
Sell
40
Ventyx Biosciences (VTYX)
is a Sell
Is Ventyx Biosciences a Buy, Sell or Hold?
- The current Ventyx Biosciences [VTYX] share price is $2.45. The Score for VTYX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VTYX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy, Sell or Hold?
- The current Regulus Therapeutics [RGLS] share price is $1.63. The Score for RGLS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RGLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTYX Stock Price Chart
What is Ventyx Biosciences's stock price today?
-
The Ventyx Biosciences share price today is $2.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTYX is experiencing slight buying pressure.
RGLS Stock Price Chart
What is Regulus Therapeutics's stock price today?
-
The Regulus Therapeutics share price today is $1.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLS is experiencing slight buying pressure.
VTYX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 58.99 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.88 - 2.42) | Buy |
Bollinger Bands (100): | (1.96 - 2.54) | Buy |
RGLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 60.52 | Buy |
Chaikin Money Flow: | 55494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.43 - 1.57) | Buy |
Bollinger Bands (100): | (1.48 - 1.7) | Buy |
VTYX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Buy |
20-day SMA: | 2.14 | Buy |
50-day SMA: | 2.2 | Buy |
200-day SMA: | 3.56 | Sell |
8-day EMA: | 2.37 | Buy |
20-day EMA: | 2.22 | Buy |
50-day EMA: | 2.22 | Buy |
200-day EMA: | 4.64 | Sell |
RGLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.55 | Buy |
20-day SMA: | 1.5 | Buy |
50-day SMA: | 1.53 | Buy |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 1.57 | Buy |
20-day EMA: | 1.53 | Buy |
50-day EMA: | 1.54 | Buy |
200-day EMA: | 1.69 | Sell |
Ventyx Biosciences Earnings Growth & VTYX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.20 per share, and a decrease next year of $0.04 per share.
Regulus Therapeutics Earnings Growth & RGLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and a decrease next year of $0.48 per share.
Ventyx Biosciences Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regulus Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |